Warren Alpert Medical School of Brown University, Office of Continuing Medical Education and
Rhode Island Department of Health Academic Center
There are 4 core strategies championed by the Governor’s Task Force on Preventing Overdose deaths, Prevention, Recovery, Treatment and Rescue. One goal of the Treatment Strategy Work Group is to increase the number of prescribers able and willing to prescribe medication assisted treatment, specifically, buprenorphine. There are several buprenorphine products available in various dosage forms. As we have seen an increase in patients treated with buprenorphine we are presented with clinical challenges in various settings such as the Emergency Department and inpatient settings regarding how to care for patients on these medications. There is some overlap with chronic pain and opioid use disorder, in some patients, buprenorphine may be a safer treatment option for a patient with chronic pain, instead of a full opioid agonist. RIDOH invites you to this thought provoking and interactive CME as we reason together on these clinical challenges and learn more about this unique group of medications.
This training meets the requirements set forth in RI Regulation 3.14 Prescriber Training Requirement for Best Practices Regarding Opioid Prescribing. This specific training requirement is required only once and must be completed before renewal of controlled substance registration or two (2) years (whichever is longer). http://sos.ri.gov/rules/index.php?page=details&erlid=8473
If you need assistance with these activities, you can call (401) 863-3337 for support.